Skip to content
PICO Portalanswers from OpenAlex

Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans

PaperCitations, authors & open-access status

Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is a paper indexed in PICO Portal from OpenAlex.

How many citations does Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans have?

PICO Portalcitation count

Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans has 344 citations in the OpenAlex counts PICO Portal stores.

When was Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans published?

PICO Portalyear

Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans has 1997 year in the PICO Portal index.

What is the open-access status of Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?

PICO Portaloa status

Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans has bronze oa status in the PICO Portal index.

What is the DOI of Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?

PICO Portaldoi

The DOI for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is on the source record.

What is the PMID of Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?

PICO Portalpmid

The PMID for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is on the source record.

What is the OpenAlex record for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans?

PICO Portalopenalex

The OpenAlex for Cyclophosphamide therapy for lupus nephritis: Poor renal survival in black Americans is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial